Coronado Biosciences (CNDO) Reports Q4 Loss of $0.10

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. NVDA
7. CRBU
8. HALO
9. BBIO
10. SPY

Go back to Coronado Biosciences (CNDO) Reports Q4 Loss of $0.10

Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

March 16, 2015 7:30 AM EDT

BURLINGTON, Mass., March 16, 2015 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq: CNDO) announced its financial results for the fourth quarter and year ended December 31, 2014.

Dr. Lindsay A. Rosenwald, Coronado's Chairman, President and CEO, said, "We have made substantial progress in 2014 and are leveraging our extensive biopharmaceutical business, financial and drug development expertise to invest in the acquisition, development and commercialization of novel pharmaceutical and other biomedical products with high growth potential. We now have multiple subsidiaries focused on a number of important, growing therapeutic areas including dermatology, post-operative pain and immuno-oncology."

Financial... More